Anthropic Sent Bankers IPO Terms of $70 to $80 a Share, per Reuters

The Terms

Anthropic's long-awaited public debut now has numbers attached to it.

The AI lab has reportedly sent bankers IPO terms of $70 to $80 a share, per Reuters. The terms give the market its first concrete anchor for pricing the offering, which is expected to be one of the largest technology listings on record.

Anthropic filed its S-1 with the SEC on October 26 and kicked off its IPO roadshow this week. The filing itself made headlines for an unusual disclosure: a catastrophic AI incident insurance warning that laid out, in a public securities document, the company's own assessment of worst-case AI risks.

A Valuation Reset

The terms land after a reset in expectations. Reporting earlier in the fall indicated Anthropic's IPO valuation expectations had been cut toward $1.5 trillion, and the $70 to $80 range will now be tested against real institutional demand during the roadshow.

The comparison set is thin. OpenAI closed an $11 billion raise at a $1.25 trillion valuation, and there is still no large, pure-play public AI model company for investors to benchmark against. Anthropic would be the first of its kind at this scale, which cuts both ways: scarcity value on one side, no established trading multiple on the other.

Anthropic has also committed to roughly $895 billion in future AI infrastructure spending through 2045, a figure that makes the IPO proceeds, and the public market's appetite for funding the AI buildout, a central part of the story.

Do you want to see how to make more plays? Do you want to find gains yourself? Unusual Whales helps you find market opportunities through our market tide, historical options flow, GEX, and much, much more. Create a free account here to start conquering the market with Unusual Whales

Options and Market Impact

A priced Anthropic deal would ripple across the AI complex. Microsoft, Amazon, and Alphabet all carry AI exposure that gets re-rated every time a private mark becomes a public one, and the chip names, Nvidia above all, trade on the assumption that lab spending continues at full speed.

Weak demand at $70 to $80 would be read as a verdict on the entire AI capital cycle. A hot deal, priced at or above the top of the range, would do the opposite, and would likely pull forward timelines for every other private AI company watching from the sidelines.

Bottom Line

Roadshows exist to find the price, and Anthropic's starts with $70 to $80 on the table. Where it lands will say as much about the market's faith in the AI buildout as it does about one company.

Follow the flow on these names and the rest of the market with Unusual Whales. Create a free account here to start conquering the market with Unusual Whales.

Track MSFT on Unusual Whales
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.